NVST Stock Analysis: Buy, Sell, or Hold?

NVST - Envista Holdings Corporation Common stock, $0.01 par value per share

DENTAL EQUIPMENT & SUPPLIES
$23.47
0.08 (0.34%) ▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 05, 2026 3d

Get Alerted When NVST Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: NVST shows positive signals but monitor for confirmation. Market pricing in 1.5% growth. Moderate conviction.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$32.65
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$20.27
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: NVST is currently trading at $23.47, which is considered fair relative to its 30-day fair value range of $22.22 to $24.32. The stock's valuation (Forward PE: 18.4) is in line with its historical norms (17.6). At these levels, the market is pricing in 1.5% annual earnings growth.

Technical Outlook: Technically, NVST is in a strong uptrend. The price is currently testing key support at $22.95. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $22.22 - $24.32
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 71.0%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($23.23)
  • BULLISH: Expecting earnings turnaround to 1.5% growth with 11.5% revenue growth

Fair Price Analysis

30-Day Fair Range $22.22 - $24.32
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $22.96
Resistance Level $25.41
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 18.43
Wall Street Target $23.23 (-1.0%)
Revenue Growth (YoY) 11.5%
Earnings Growth (YoY) -27.2%
Profit Margin 0.6%
Valuation Premium vs History +1.5% premium
PE vs Historical 18.4 vs 17.6 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.5% (market-implied from PE analysis)
1-Year Target $23.82 (+2%)
2-Year Target $24.18 (+3%)
3-Year Target $24.54 (+5%)
3-Yr Target (if PE normalizes) (PE: 18→18) PE COMPRESSION $23.43 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 11.7%) $39.53 (+68%)
Base: (SPY PE: 18.4, Growth: 11.7%) $32.68 (+39%)
Bear: (PE: 15.7, Growth: 11.7%) $27.78 (+18%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Forward PE: 19.57 | Forward EPS (Implied): $1.20
Bull Case $28.34 (+21%)
Analyst growth 15.0%, PE expands to 20.6
Base Case $23.47 (0%)
Market implied 0.0%, PE stable at 19.6
Bear Case $17.95 (-24%)
Severe decline -15.0%, PE contracts to 17.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 9:18 PM ET
Data refreshes hourly during market hours. Next update: 10:18 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Featured in Portfolios

NVST is a key holding in these high-performance investment strategies.

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALC
Alcon AG
STRONG BUY
27 analysts
$92 63 BUY
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$608 58 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$191 58 HOLD
RMD
ResMed Inc
BUY
19 analysts
$292 57 HOLD
ALGN
Align Technology Inc
BUY
18 analysts
$184 62 BUY

Advanced NVST Option Strategies

Professional options setups generated by AI based on today's NVST price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NVST

NVST Technical Chart NVST Price Prediction NVST Earnings Date NVST Investment Advisor NVST Fair Price Analyzer NVST Options Advisor NVST Options Chain NVST Options Analysis NVST Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals